![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neutrophils in COVID-19
Nico Reusch, Elena De Domenico, Lorenzo Bonaguro, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 248
Nico Reusch, Elena De Domenico, Lorenzo Bonaguro, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 248
Showing 1-25 of 248 citing articles:
Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19
Sarthak Sinha, Nicole L. Rosin, Rohit Arora, et al.
Nature Medicine (2021) Vol. 28, Iss. 1, pp. 201-211
Open Access | Times Cited: 187
Sarthak Sinha, Nicole L. Rosin, Rohit Arora, et al.
Nature Medicine (2021) Vol. 28, Iss. 1, pp. 201-211
Open Access | Times Cited: 187
Innate immunological pathways in COVID-19 pathogenesis
Søren R. Paludan, Trine H. Mogensen
Science Immunology (2022) Vol. 7, Iss. 67
Closed Access | Times Cited: 155
Søren R. Paludan, Trine H. Mogensen
Science Immunology (2022) Vol. 7, Iss. 67
Closed Access | Times Cited: 155
COVID-19 and cellular senescence
Clemens A. Schmitt, Tamar Tchkonia, Laura J. Niedernhofer, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 4, pp. 251-263
Open Access | Times Cited: 97
Clemens A. Schmitt, Tamar Tchkonia, Laura J. Niedernhofer, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 4, pp. 251-263
Open Access | Times Cited: 97
The role of neutrophil extracellular traps in acute lung injury
Davide Scozzi, Fuyi Liao, Alexander S. Krupnick, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 95
Davide Scozzi, Fuyi Liao, Alexander S. Krupnick, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 95
Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis
Zheng Gong, Qing Li, Jiayuan Shi, et al.
Science Immunology (2023) Vol. 8, Iss. 80
Open Access | Times Cited: 52
Zheng Gong, Qing Li, Jiayuan Shi, et al.
Science Immunology (2023) Vol. 8, Iss. 80
Open Access | Times Cited: 52
Neutrophils in COVID-19: recent insights and advances
Jiayu Li, Kegong Zhang, Ye Zhang, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 37
Jiayu Li, Kegong Zhang, Ye Zhang, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 37
Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 36
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 36
Risk factors for Coronavirus disease-associated mucormycosis
Umang Arora, Megha Priyadarshi, Varidh Katiyar, et al.
Journal of Infection (2021) Vol. 84, Iss. 3, pp. 383-390
Open Access | Times Cited: 55
Umang Arora, Megha Priyadarshi, Varidh Katiyar, et al.
Journal of Infection (2021) Vol. 84, Iss. 3, pp. 383-390
Open Access | Times Cited: 55
Aging, inflammaging and immunosenescence as risk factors of severe COVID-19
Anteneh Mehari Tizazu, Hylemariam Mihiretie Mengist, Gebreselassie Demeke
Immunity & Ageing (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 52
Anteneh Mehari Tizazu, Hylemariam Mihiretie Mengist, Gebreselassie Demeke
Immunity & Ageing (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 52
Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures
Patrick Taeschler, Carlo Cervia, Yves Zurbuchen, et al.
Allergy (2022) Vol. 77, Iss. 8, pp. 2415-2430
Open Access | Times Cited: 50
Patrick Taeschler, Carlo Cervia, Yves Zurbuchen, et al.
Allergy (2022) Vol. 77, Iss. 8, pp. 2415-2430
Open Access | Times Cited: 50
Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients
Thomas J. LaSalle, Anna L.K. Gonye, Samuel S. Freeman, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100779-100779
Open Access | Times Cited: 50
Thomas J. LaSalle, Anna L.K. Gonye, Samuel S. Freeman, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100779-100779
Open Access | Times Cited: 50
Programmed cell death: the pathways to severe COVID-19?
Stefanie M. Bader, James P. Cooney, Marc Pellegrini, et al.
Biochemical Journal (2022) Vol. 479, Iss. 5, pp. 609-628
Open Access | Times Cited: 45
Stefanie M. Bader, James P. Cooney, Marc Pellegrini, et al.
Biochemical Journal (2022) Vol. 479, Iss. 5, pp. 609-628
Open Access | Times Cited: 45
Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States
Lena F. Schimke, Alexandre H. C. Marques, G. Baiocchi, et al.
Cells (2022) Vol. 11, Iss. 5, pp. 847-847
Open Access | Times Cited: 39
Lena F. Schimke, Alexandre H. C. Marques, G. Baiocchi, et al.
Cells (2022) Vol. 11, Iss. 5, pp. 847-847
Open Access | Times Cited: 39
An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution
Francisco Javier Gil‐Etayo, Sara Garcinuño, Alberto Utrero‐Rico, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 296-296
Open Access | Times Cited: 35
Francisco Javier Gil‐Etayo, Sara Garcinuño, Alberto Utrero‐Rico, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 296-296
Open Access | Times Cited: 35
Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model
Flávio P. Veras, Giovanni Freitas Gomes, Bruna M. S. Silva, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 35
Flávio P. Veras, Giovanni Freitas Gomes, Bruna M. S. Silva, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 35
Photophysical Mechanisms of Photobiomodulation Therapy as Precision Medicine
Ann Liebert, William Capon, Junxiong Pang, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 237-237
Open Access | Times Cited: 33
Ann Liebert, William Capon, Junxiong Pang, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 237-237
Open Access | Times Cited: 33
A Decision Support System for Diagnosis of COVID-19 from Non-COVID-19 Influenza-like Illness Using Explainable Artificial Intelligence
Krishnaraj Chadaga, Srikanth Prabhu, Vivekananda Bhat K, et al.
Bioengineering (2023) Vol. 10, Iss. 4, pp. 439-439
Open Access | Times Cited: 30
Krishnaraj Chadaga, Srikanth Prabhu, Vivekananda Bhat K, et al.
Bioengineering (2023) Vol. 10, Iss. 4, pp. 439-439
Open Access | Times Cited: 30
Neutrophil extracellular traps and long COVID
Areez Shafqat, Mohamed H. Omer, Ibrahem Albalkhi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Areez Shafqat, Mohamed H. Omer, Ibrahem Albalkhi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Quantitative proteomics reveals tissue-specific, infection-induced and species-specific neutrophil protein signatures
Gabriel Sollberger, Alejandro J. Brenes, Jordan Warner, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Gabriel Sollberger, Alejandro J. Brenes, Jordan Warner, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Inflammation in the COVID-19 airway is due to inhibition of CFTR signaling by the SARS-CoV-2 spike protein
H. Caohuy, Ofer Eidelman, Tinghua Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
H. Caohuy, Ofer Eidelman, Tinghua Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Selective phosphodiesterase 4 inhibitor roflumilast reduces inflammation and lung injury in models of betacoronavirus infection in mice
Vinícius Amorim Beltrami, Flávia Rayssa Braga Martins, Débora Gonzaga Martins, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Open Access
Vinícius Amorim Beltrami, Flávia Rayssa Braga Martins, Débora Gonzaga Martins, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Open Access
The essential role of prebiotics in restoring gut health in long COVID
Alberto Rubio‐Casillas, César Manuel Rodríguez-Quintero, Altijana Hromić-Jahjefendić, et al.
Progress in molecular biology and translational science (2025)
Closed Access
Alberto Rubio‐Casillas, César Manuel Rodríguez-Quintero, Altijana Hromić-Jahjefendić, et al.
Progress in molecular biology and translational science (2025)
Closed Access
The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery
Eleni Syrimi, Éanna Fennell, Alex Richter, et al.
iScience (2021) Vol. 24, Iss. 11, pp. 103215-103215
Open Access | Times Cited: 45
Eleni Syrimi, Éanna Fennell, Alex Richter, et al.
iScience (2021) Vol. 24, Iss. 11, pp. 103215-103215
Open Access | Times Cited: 45
Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy
Xia Li, Mi Shao, Xiangjun Zeng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 42
Xia Li, Mi Shao, Xiangjun Zeng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 42
Mechanism for the attenuation of neutrophil and complement hyperactivity by MSC exosomes
Jia Tong Loh, Bin Zhang, Joey Kay Hui Teo, et al.
Cytotherapy (2022) Vol. 24, Iss. 7, pp. 711-719
Open Access | Times Cited: 33
Jia Tong Loh, Bin Zhang, Joey Kay Hui Teo, et al.
Cytotherapy (2022) Vol. 24, Iss. 7, pp. 711-719
Open Access | Times Cited: 33